Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st

Rhea-AI Summary

Enveric Biosciences (NASDAQ:ENVB) announced that CEO David Johnson will present at the Planet MicroCap Showcase on April 21, 2021, at 9:00 a.m. ET. This virtual event aims to highlight the company's innovative cannabinoid medicines designed for cancer patients, particularly addressing issues like radiodermatitis and chemotherapy-induced neuropathy. Interested participants can register for the live presentation and access additional conference details through provided links. The company's commitment to patient-first solutions is emphasized throughout the announcement.

NAPLES, FL / ACCESSWIRE / April 14, 2021 / Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will present at the Planet MicroCap Showcase to be held virtually on Wednesday, April 21, 2021 at 9:00 a.m. ET. To access the live presentation, please register here.

For more information regarding the conference, or to schedule a one-on-one meeting with Enveric's management team, please contact KCSA Strategic Communications at EnvericBio@kcsa.com or register for the virtual event here.

If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN.Network.

If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

About Enveric Biosciences

Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. For more information, please visit https://www.enveric.com/.

Investor Contacts

Valter Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
valter@kcsa.com / asoss@kcsa.com

Media Contacts

Caitlin Kasunich / Raquel Cona
KCSA Strategic Communications
212.896.1241 / 516.779.2630
ckasunich@kcsa.com / rcona@kcsa.com

SOURCE: Enveric Biosciences via SNN Network

View source version on accesswire.com:
https://www.accesswire.com/640222/Enveric-Biosciences-to-Participate-in-the-Planet-MicroCap-Showcase-on-April-21st

FAQ

When is Enveric Biosciences presenting at the Planet MicroCap Showcase?

Enveric Biosciences will present on April 21, 2021, at 9:00 a.m. ET.

What is Enveric Biosciences focusing on in its presentation?

The focus will be on developing cannabinoid medicines for cancer patients, specifically addressing radiodermatitis and chemotherapy-induced neuropathy.

How can I register for the Planet MicroCap Showcase?

You can register for the Planet MicroCap Showcase by following the link provided in the press release.

Will the presentation be available after the live event?

Yes, all company presentations will be available as webcasts on the conference event platform.

What is the stock symbol for Enveric Biosciences?

The stock symbol for Enveric Biosciences is ENVB.